M/I Homes Q4 Earnings, Revenue Rise-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

M/I Homes Q4 Earnings, Revenue Rise

Jan 29, 2025 5:22 AM

07:46 AM EST, 01/29/2025 (MT Newswires) -- M/I Homes ( MHO ) reported Q4 earnings Wednesday of $4.71 per diluted share, up from $3.66 a year earlier.

Two analysts polled by FactSet expected $4.88.

Revenue for the quarter ended Dec. 31 was $1.21 billion, compared with $972.6 million a year earlier.

Analysts polled by FactSet expected $1.17 billion.

Previous page： BRIEF-Bitfarms To Acquire Stronghold Digital Mining Next page： NEWSMAKER-Revolut's Storonsky takes big step forward in battle with the banks

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Bitfarms To Acquire Stronghold Digital Mining

Aug 24, 2024

Aug 21 (Reuters) - Bitfarms Ltd ( BITF ): * BITFARMS TO ACQUIRE STRONGHOLD DIGITAL MINING * BITFARMS LTD ( BITF ) - TO ACQUIRE STRONGHOLD IN US$125 MILLION STOCK-FOR-STOCK MERGER * BITFARMS LTD ( BITF ): DEAL TO ALSO INCLUDE ASSUMPTION OF DEBT VALUED AT ABOUT US$50 MILLION * BITFARMS ( BITF )- STRONGHOLD SHAREHOLDERS TO RECEIVE 2.52 SHARES...

NEWSMAKER-Revolut's Storonsky takes big step forward in battle with the banks

Aug 24, 2024

* Revolut valued at $45 bln in employee share sale * Valuation exceeds that of Barclays ( JJCTF ), Natwest ( NWG ) * Storonsky's stake worth around $8 bln, Reuters calculations show * Former banker launched Revolut in 2015 By Tommy Reggiori Wilkes, Amy-Jo Crowley LONDON, Aug 22 (Reuters) - Revolut founder and CEO Nik Storonsky had a simple...

Eli Lilly Alzheimer's drug to be blocked for use by NHS, The Telegraph reports

Aug 24, 2024

Aug 23 (Reuters) - Eli Lilly's ( LLY ) treatment for early Alzheimer's is expected to be blocked for use by Britain's National Health Service (NHS), The Telegraph reported on Friday. The drug donanemab would be rejected by the National Institute for Health and Care Excellence (NICE), which decides what drugs are available on the NHS, the newspaper reported citing...

Draganfly Sets September 3 for Share Consolidation

Aug 24, 2024

04:46 PM EDT, 08/23/2024 (MT Newswires) -- Draganfly ( DPRO ) , a drone solutions and systems developer, announced Friday its board has approved the consolidation of its issued and outstanding common shares on the basis of one post-consolidated Common Share for every 25 pre-consolidated Common Shares for Sept. 3, 2024. After the Consolidation, the Common Shares will be reduced...